The US will let Novo Nordisk A/S sell it blockbuster weight loss drug Wegovy in a pill form. Millions of people already take the shot. A trial showed people taking a 25 milligram pill once daily lost about 13.6% of their body weight over 64 weeks. Novo President and CEO Mike Doustdar speaks to Bloomberg's Katie Greifeld. -------- More on Bloomberg Television and Markets Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance: https://